NCLEX Pharm Cheat Sheet, Cheat Sheet of Pharmacology

Hematology pharm NCLEX cheat sheet

Typology: Cheat Sheet

2025/2026

Uploaded on 02/12/2026

maxine-nusinow
maxine-nusinow ๐Ÿ‡บ๐Ÿ‡ธ

17 documents

1 / 1

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NCLEX Quick Sheet โ€“ Hematology & Blood Disorder
Pharmacology
โ€ขHeparin (UFH) โ€“ Binds antithrombin III โ†’ inactivates IIa & Xa. Monitor aPTT (1.5โ€“2.5ร— normal). Antidote:
Protamine sulfate. Watch for HIT: โ†“ platelets >50%, new thrombosis.
โ€ขLow-Molecular-Weight Heparin (enoxaparin) โ€“ Inhibits Xa > IIa. Predictable dosing, no aPTT monitoring.
Adjust dose for renal impairment. Partial protamine reversal.
โ€ขWarfarin โ€“ Inhibits vitamin K-dependent factors II, VII, IX, X. Monitor INR (2โ€“3 typical; 2.5โ€“3.5 mechanical
valves). Antidote: Vitamin K or PCC. Bridge with heparin when starting.
โ€ขDOACs โ€“ Dabigatran (IIa inhibitor), Apixaban/Rivaroxaban/Edoxaban (Xa inhibitors). No routine labs.
Antidotes: Idarucizumab (dabigatran), Andexanet alfa (Xa inhibitors). Hold before surgery based on renal
function.
โ€ขAspirin โ€“ Irreversible COX-1 inhibition โ†’ โ†“ TXA2 โ†’ โ†“ platelet aggregation. Stop 7 days pre-op. NCLEX:
Watch for GI bleeding, tinnitus, avoid with viral illness (Reyeโ€™s).
โ€ขClopidogrel โ€“ Irreversible P2Y12 blockade โ†’ โ†“ platelet aggregation. Used for stents/ACS. Avoid with PPIs
(omeprazole). Monitor for bleeding, TTP.
โ€ขGlycoprotein IIb/IIIa Inhibitors (abciximab, eptifibatide, tirofiban) โ€“ Prevent final common platelet aggregation
step. IV use in PCI/ACS. Monitor platelets; risk of bleeding/thrombocytopenia.
โ€ขThrombolytics (tPA/alteplase) โ€“ Convert plasminogen โ†’ plasmin to dissolve clots. Use for stroke, MI, PE.
Contraindicated if recent surgery, trauma, hemorrhage. NCLEX: Get CT before stroke tPA; monitor for ICH.
โ€ขOral Iron (ferrous sulfate) โ€“ Take with vitamin C; avoid antacids/dairy/tea. SE: constipation, dark stools.
NCLEX: Use straw for liquid; keep from children (toxic).
โ€ขIV Iron (iron sucrose, ferric carboxymaltose) โ€“ Used if oral not tolerated. Monitor for anaphylaxis,
hypotension. NCLEX: Emergency kit ready during infusion.
โ€ขVitamin B12 (cyanocobalamin) โ€“ IM for pernicious anemia or post-gastrectomy. NCLEX: Treat B12 deficiency
before folate to avoid worsening neuro symptoms.
โ€ขFolic Acid โ€“ Prevents neural tube defects, treats megaloblastic anemia. Check B12 first. Interacts with
methotrexate and phenytoin.
โ€ขErythropoiesis-Stimulating Agents (epoetin alfa, darbepoetin) โ€“ Stimulate RBC production in CKD/chemo.
NCLEX: Target Hgb 10โ€“11 g/dL; hold if >11; monitor BP; need adequate iron.
โ€ขGranulocyte Colony-Stimulating Factor (filgrastim, pegfilgrastim) โ€“ โ†‘ neutrophils after chemo. SE: bone pain,
splenomegaly. NCLEX: Give โ‰ฅ24h after chemo; monitor CBC.
โ€ขRomiplostim โ€“ TPO receptor agonist for ITP. SE: HA, thrombosis if platelets too high. NCLEX: Weekly
platelet monitoring; avoid abrupt stop (rebound thrombocytopenia).
โ€ขNCLEX Hematology Tip โ€“ Always monitor CBC, aPTT/INR when indicated, avoid IM injections in
anticoagulated patients, and assess for bleeding/bruising with all antithrombotics.

Partial preview of the text

Download NCLEX Pharm Cheat Sheet and more Cheat Sheet Pharmacology in PDF only on Docsity!

NCLEX Quick Sheet โ€“ Hematology & Blood Disorder

Pharmacology

  • Heparin (UFH) โ€“ Binds antithrombin III^ โ†’^ inactivates IIa & Xa. Monitor aPTT (1.5โ€“2.5ร— normal). Antidote: Protamine sulfate. Watch for HIT: โ†“ platelets >50%, new thrombosis.
  • Low-Molecular-Weight Heparin (enoxaparin) โ€“ Inhibits Xa > IIa. Predictable dosing, no aPTT monitoring. Adjust dose for renal impairment. Partial protamine reversal.
  • Warfarin โ€“ Inhibits vitamin K-dependent factors II, VII, IX, X. Monitor INR (2โ€“3 typical; 2.5โ€“3.5 mechanical valves). Antidote: Vitamin K or PCC. Bridge with heparin when starting.
  • DOACs โ€“ Dabigatran (IIa inhibitor), Apixaban/Rivaroxaban/Edoxaban (Xa inhibitors). No routine labs. Antidotes: Idarucizumab (dabigatran), Andexanet alfa (Xa inhibitors). Hold before surgery based on renal function.
  • Aspirin โ€“ Irreversible COX-1 inhibition^ โ†’^ โ†“^ TXA2^ โ†’^ โ†“^ platelet aggregation. Stop 7 days pre-op. NCLEX: Watch for GI bleeding, tinnitus, avoid with viral illness (Reyeโ€™s).
  • Clopidogrel โ€“ Irreversible P2Y12 blockade^ โ†’^ โ†“^ platelet aggregation. Used for stents/ACS. Avoid with PPIs (omeprazole). Monitor for bleeding, TTP.
  • Glycoprotein IIb/IIIa Inhibitors (abciximab, eptifibatide, tirofiban) โ€“ Prevent final common platelet aggregation step. IV use in PCI/ACS. Monitor platelets; risk of bleeding/thrombocytopenia.
  • Thrombolytics (tPA/alteplase) โ€“ Convert plasminogen^ โ†’^ plasmin to dissolve clots. Use for stroke, MI, PE. Contraindicated if recent surgery, trauma, hemorrhage. NCLEX: Get CT before stroke tPA; monitor for ICH.
  • Oral Iron (ferrous sulfate) โ€“ Take with vitamin C; avoid antacids/dairy/tea. SE: constipation, dark stools. NCLEX: Use straw for liquid; keep from children (toxic).
  • IV Iron (iron sucrose, ferric carboxymaltose) โ€“ Used if oral not tolerated. Monitor for anaphylaxis, hypotension. NCLEX: Emergency kit ready during infusion.
  • Vitamin B12 (cyanocobalamin) โ€“ IM for pernicious anemia or post-gastrectomy. NCLEX: Treat B12 deficiency before folate to avoid worsening neuro symptoms.
  • Folic Acid โ€“ Prevents neural tube defects, treats megaloblastic anemia. Check B12 first. Interacts with methotrexate and phenytoin.
  • Erythropoiesis-Stimulating Agents (epoetin alfa, darbepoetin) โ€“ Stimulate RBC production in CKD/chemo. NCLEX: Target Hgb 10โ€“11 g/dL; hold if >11; monitor BP; need adequate iron.
  • Granulocyte Colony-Stimulating Factor (filgrastim, pegfilgrastim) โ€“^ โ†‘^ neutrophils after chemo. SE: bone pain, splenomegaly. NCLEX: Give โ‰ฅ24h after chemo; monitor CBC.
  • Romiplostim โ€“ TPO receptor agonist for ITP. SE: HA, thrombosis if platelets too high. NCLEX: Weekly platelet monitoring; avoid abrupt stop (rebound thrombocytopenia).
  • NCLEX Hematology Tip โ€“ Always monitor CBC, aPTT/INR when indicated, avoid IM injections in anticoagulated patients, and assess for bleeding/bruising with all antithrombotics.